OrthoSensor and McLaren Applied formed EnMovi to expand development of MOTIONSENSE™ wearable smart sensor technology and ORTHOLOGIQ® data analytics for use in orthopedic patient care.
The venture pairs OrthoSensor's years of experience in intelligent sensor-assisted technology with McLaren's Formula 1-derived insights into applications for software, sensor technology, predictive analytics and design.
Specifically, OrthoSensor's expertise in quantifying orthopedic data through sensor-assisted technology allows healthcare providers to deliver evidence-based treatments to improve clinical and economic outcomes. With the support of McLaren's quantifiable technology and machine learning capabilities, the new venture will develop MOTIONSENSE and ORTHOLOGIQ to monitor a patient's care path pre-, intra- and post-operatively.
"We are excited about this strategic venture with OrthoSensor, Inc. and McLaren Applied. It will bring our current products OrthoLogIQ and MotionSense to the next level, and most significantly augment orthopedic treatment and surgery globally," said Ivan Delevic, President and Chief Executive Officer of OrthoSensor and Chairman of the Board of EnMovi Ltd. "As pressure rises to better manage the orthopedic patient's journey and outcomes, these two products will help surgeons and hospitals consistently track patients throughout the continuum of care."
Dr. Martin Roche, Founder and Chief Medical Officer of OrthoSensor, is a veteran in the world of smart devices, robotics and sensors. He feels that the orthopedic community is slowly focusing on data to improve the patient’s pre-operative status and implement surgical pathways to standardize treatment. The next step will be monitoring of outcomes through post-op connectivity and wearables. See where Dr. Roche thinks we'll be with technology, in five years.